Several studies have provided epidemiological data indicating involvement of hPRL in cancer development, specifically in breast, prostate and, as recently shown by our group, colorectal cancer (Tworoger et al, 2007; Harvey et al, 2008; Tworoger and Hankinson, 2008; Harbaum et al, 2010). The gene discussed is PRLR; the disease is cancer.